Melanoma
Melanoma screenings should be conducted in first-degree relatives of recently diagnosed patients
Published in Clinical Oncology Week, November 6th, 2006
According to recent research published in the journal Cancer, "Identifying high-risk individuals for melanoma education and risk reduction may be a viable strategy to curb the incidence of melanoma, which has risen precipitously in the past 50 years. The first-degree relatives of melanoma patients represent a risk group who may experience a 'teachable moment' for enhanced education and risk reduction."
"We report a randomized trial testing an intervention that provided personalized telephone counseling and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Cervical Cancer
Selected Stage III cervical cancer patients treated by high-dose-rate brachytherapy - Gastrinoma
Zollinger-Ellison syndrome patients should undergo routine surgical exploration - Leukemia
Myelodysplastic syndrome patients benefited from azacitidine - Clinical Trials
Studies from Massachusetts General Hospital, Department of Radiation Oncology yield new information about clinical trials - Drug Discovery
Research from Bristol-Myers Squibb Company, Inc. yields new data on drug discovery - Granuloma Prevention
Studies from University of Amsterdam, Department of Oral and Maxillofacial Surgery update current data on granuloma prevention - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
